Provided by Tiger Fintech (Singapore) Pte. Ltd.

CureVac B.V.

3.19
-0.0200-0.62%
Post-market: 3.250.0600+1.88%19:52 EDT
Volume:325.13K
Turnover:1.04M
Market Cap:718.25M
PE:4.28
High:3.27
Open:3.24
Low:3.16
Close:3.21
Loading ...

CureVac Nv - Patient Treatment Anticipated to Start in Second Half of 2025

THOMSON REUTERS
·
07 Apr

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

ACCESS Newswire
·
07 Apr

Is CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?

Insider Monkey
·
03 Apr

CureVac (CVAC) Gets a Hold from Leerink Partners

TIPRANKS
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed

Reuters
·
29 Mar

CureVac Shares Rise on Patent Confirmation Amid BioNTech Lawsuit

Dow Jones
·
29 Mar

U.S.-Listed Shares of CureVac Rise 15.3% After Co's Mrna Patent Upheld by European Patent Office

THOMSON REUTERS
·
28 Mar

U.S.-Listed Shares of CureVac Rise 16% Premarket After Co's Mrna Patent Upheld by European Patent Office

THOMSON REUTERS
·
28 Mar

BUZZ-U.S. STOCKS ON THE MOVE -CureVac, gold miners, Rocket Lab

Reuters
·
28 Mar

CureVac Patent Validated in BioNTech Dispute, Infringement Hearing Set for July

MT Newswires Live
·
28 Mar

CureVac says European Patent Office dismissed BioNTech opposition

TIPRANKS
·
28 Mar

BUZZ-CureVac rises on COVID vaccine patent decision

Reuters
·
28 Mar

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ACCESS Newswire
·
28 Mar

BRIEF-Curevac Receives Positive Validity Decision From European Patent Office In Litigation Against Biontech SE

Reuters
·
28 Mar

Eqs-News: CureVac Receives Positive Validity Decision From European Patent Office in Litigation Against BioNTech Se

THOMSON REUTERS
·
28 Mar

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31%

Simply Wall St.
·
10 Mar

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

ACCESS Newswire
·
18 Feb

Analysts’ Top Healthcare Picks: CureVac (CVAC), GE Healthcare Technologies Inc (GEHC)

TIPRANKS
·
14 Feb

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential

Simply Wall St.
·
11 Feb

Four Years After Covid-19 Success, mRNA Vaccines Aren't Ready for Bird Flu -- Barrons.com

Dow Jones
·
25 Jan